Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Prepaid Assets: 2018-2025

Historic Prepaid Assets for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Mar 2025 value amounting to $319,058.

  • China SXT Pharmaceuticals' Prepaid Assets rose 354.02% to $305,137 in Q3 2025 from the same period last year, while for Sep 2025 it was $305,137, marking a year-over-year increase of 354.02%. This contributed to the annual value of $319,058 for FY2025, which is 908.59% up from last year.
  • Latest data reveals that China SXT Pharmaceuticals reported Prepaid Assets of $319,058 as of FY2025, which was up 908.59% from $31,634 recorded in FY2024.
  • China SXT Pharmaceuticals' Prepaid Assets' 5-year high stood at $1.9 million during FY2021, with a 5-year trough of $31,634 in FY2024.
  • In the last 3 years, China SXT Pharmaceuticals' Prepaid Assets had a median value of $230,642 in 2023 and averaged $193,778.
  • Its Prepaid Assets has fluctuated over the past 5 years, first slumped by 86.28% in 2024, then spiked by 908.59% in 2025.
  • China SXT Pharmaceuticals' Prepaid Assets (Yearly) stood at $1.9 million in 2021, then slumped by 53.49% to $864,709 in 2022, then tumbled by 73.33% to $230,642 in 2023, then crashed by 86.28% to $31,634 in 2024, then soared by 908.59% to $319,058 in 2025.